Cel­gene stays fo­cused on pro­tein home­osta­sis, backs Cleave’s $37M round to fu­el ear­ly stud­ies

Cleave Bio­sciences CEO Lau­ra Shawver has built out her ven­ture syn­di­cate, adding can­cer pow­er­house Cel­gene to the mix and mak­ing key ad­di­tions to the board …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.